NVAX breakoutNVAX finally managed to breakout.
I will be looking for an entry tomorrow above today's high
NVAX trade ideas
Novavax LongStrong support line on 122.12$. Firs target on 160$, second - 206$. Stop Limit on 118$. P/L ratio 1:1 for firs target & 3:1.
NVAX ShortSupply Zone
11/04 earning
Short Entry 162
Stop 175
Target1 120
Target2 80
Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.
Brutal Pullback, But What's Next?In short, they most likely bounce from this level for a short time, but whether they continue their bull run or not depends on price action in the next couple weeks. I have some remarks on the charts that might help following up with their moves. The RSI for all three companies are in oversold area and historically we have seen them move back up when they hit 30 RSI.
Two of these companies (MRNA and NVAX) are testing their trendline and have a good chance of going back up and staying above their 200 MA. NVAX is under its 200 MA but its RSI and trendline is in favor of its bounce.
BNTX has broken its trendline but should test the line before deciding on its direction. If it manages to get back above the trendline with volume, then it may continue its bull run, otherwise we should see it going down. See the MAs and RSI on these charts. The only concerning factor might be the large red volumes in the last few trading days, but comparing to previous bearish moves they are not significantly larger. Still something to watch for.
Overall, there is high chance of them bouncing back up for a short time, but this could also be a sign for a larger pullback after a quick break.
Novavax ShortPfizer's monopoly is very strong on the Covid-19 vaccines . They are spending millions hiding their side effects and creating hurdles for their competitors at the regulatory agencies SUCCESSFULLY . It maybe that Novavax has one the best products out there but that simply does not matter at this point , we know how powerful big pharma can be and Novavax's lateness to the game will not serve them well here . The biggest dangers to NVAX are now the regulatory agencies taking long/asking for additional info and the COVID-19 Antiviral drug news ( Merck's pill approval will be this months and Pfizer may come out with their Phase III study result any moment now). Both are very likely .
NVAX will likely reject braking $200 TODAY. $195 -$200 will be a great entry point for a opening a short position on this . RISK /REWARD RATIO VERY LUCRATIVE .
NVAX bottomed target 160-180Lots to like here - heavily abused over the past month, bouncing off previous relative low/support, possible falling wedge break to the upside, MACD starting to turn up, 50 and 200 day MAs around the 190-200 level. 160 looks almost certain while 180 is not out of the question. might take a few sessions to pop through - earnings coming up early november.
Back to test ATH?) Get 80% upside!The paper returns to the support zone. Now there is strong news on the creation of a new generation of coronovirus vaccine. It's still relevant right now. The potential is as high as $300. That's +80%. But don't forget to lock in your position as early as possible.
❤️ If you find this helpful and want more FREE forecasts in TradingView
. . . . . Please show your support back,
. . . . . . . . Hit the 👍 LIKE button,
. . . . . . . . . . . Drop some feedback below in the comment!
❤️ Your Support is very much 🙏 appreciated!❤️
💎 Want us to help you become a better Stock trader?
Now, It's your turn!
Be sure to leave a comment let us know how do you see this opportunity and forecast.
🧐on watch for continuation💯
higher low is in on $NVAX !
but now we are approaching a big resistance, watch for a move over 180-190 then we can target 255-280!
NVAXThe same result? Nine out of ten chance of this worst stock to buy right now. Among this brand stock are two components if your currently holding this company, especially for the long term, you're not OK – this is simply places where investors should avoid putting new money at the moment.
NVAX BUY (NOVAVAX INC)Hi there.
Price is forming a continuation pattern to the upside.
Watch strong price action at the current levels for buy.
Ripe to RallyThis one looks like geared up for the next run up. Took a small long position on this today.
Pull Back Fishing Head and Shoulders Gap Down CandlesLooks like a head and shoulders top and the neckline was broken a while back. Bad news about the vaccine caused a gap down. Appears NVAX has hit the 100% down target for the ugly top, but does not always mean it is over as it can be an extension as well.
Sometimes looking at a candle that forms on the day of the gap down can help. This one made large gains at this moment from the low of the day and has broken through the resistance from a prior gap down. Right now (this can change by close) there is a bullish green candle which is a healthy candle to gap down on. A Doji (indecision) can be a good one as well as folks are not sure about price being so low after a gap down. A red candle with a long top wick would be perhaps the most bearish scenario for a gap down candle. But when price makes dramatic drops, there can be further declines on another day especially if there is anymore bad news or any more delays on vaccine.
A close above the resistance/orange line/would turn this line green and become support. Daily low or initial gap down took price to 115 at market open.
Some may guesstimate where a head and shoulders top may go by drawing a line from the head to the neckline, then projecting this line down from the neckline.
Weekly candle is indeterminate right now and is a spinning top at this moment. Bad wick on yesterday's red candle. Long top wick with no bottom shadow/tail. You can bet a candle will eventually form a tail ( and you will win (o: if there is not one so you can easily guess price is going down.
No recommendation but I plan to keep an eye on it (o:
NVAX next weekly support with low rsi
what a perfect gap down with low rsi. I am buying extra time for this to work for us. I am loving the low rsi and this gap down on it today.
NVAX DUMP CONTINUES The charts dont lie. Vaccine company do. This company is not even worth $10. Earnings in 9 days they will have to report that the company cannot produce and wasnt intending on every producing.
$NVAX Novavax On Major Support Zone
Hopefully you find the chart helpful in terms of Supports & Resistance etc.
we refrain from adding commentary on the chart as that is reserved for our members and we are very conscious of not giving financial or trading advice.
Thank you for taking time to consult our chart and we would really appreciate a like, follow or comment.
Novavax (Nasdaq NVAX)Heavy accumulation activies sighted since March.
Is this the time for NVAX to catch up with its peers?
NVAX bull thesisThis is a Part 2 from what I posted earlier. I posted a bear thesis of NVAX first. Nvax has downside to $30 or upside beyond $700 if it can get past the barriers it has up. It needs news to move it.
The bearish side of things for NVAX, historical pattern analysisI am using historical patterns to predict the future for this stock. There are reasons to think this stock will be bullish, however, historical analysis shows that NVAX might be nearing its end. I am only pointing to direction here and not using fib levels in order to make the chart as easy as possible to follow
Novavax ShortThe truth about Novavax is that execs like Stanley Erck , Gregory Glenn , John Trizzino and John Hermann are taking orders from financial institutions like Blackrock , Vanguard , RA Capital... they short & go long NVAX along with them through their family members/friends . There is more money for them in these stock fluctuations than getting the vaccine FINALLY to the market. Everybody thinks that they lost the vaccine race but there was never a race from the start , Novavax's purpose was to enrich its executives and the institutions who orchestrated this stock's parabolic moves (either ups or downs) . Iran (a country under the harshest sanctions) produced their own effective vaccine (Barekat) in less than 8 months but somehow $NVAX with the biggest pharma companies in the world as its partners could not STILL get their vaccine approved anywhere . I m not gonna say it is gonna go up or down but all I can say is that there is a lost of shenanigans are going on behind the scene .
NVAX Short Novavax will issue a statement ahead of their upcoming earnings in a couple of weeks that they have scrapped the plans for a Covid-19 vaccine and now instead they are working on a Covid-flu combo for the next year . The insiders and the main hedge fund manager Peter Kolchinsky have already shorted the stock last week . I fully expect It will be anywhere between $40-$77 in three weeks time . Good luck !
